Publication | Closed Access
1,25-DIHYDROXYVITAMIN D3 PROLONGS GRAFT SURVIVAL WITHOUT COMPROMISING HOST RESISTANCE TO INFECTION OR BONE MINERAL DENSITY1
83
Citations
14
References
1998
Year
The use of 1,25-dihydroxyvitamin D3 and its analogs to increase transplant survival will avoid bone loss and opportunistic infection, two important disadvantages of the most widely used transplant antirejection drugs--CsA and the glucocorticoids.
| Year | Citations | |
|---|---|---|
Page 1
Page 1